Basifungin

Star0

DB14058ExperimentalSmall molecule

Basifungin, also known as aureuobacidin A, is a phosphorylceramide synthase inhibitor , .

Mechanism: Pharmacologically active on Inositol phosphorylceramide synthase
Curator reviewed
Formula / weight: C₆₀H₉₂N₈O₁₀ · 1085.442 g/mol (avg)
Also known as: Aureobasidin A
Code names: Antibiotic R106I · LY 295337 · NK 204 · R106-1

Resolves to

Compound

UNIIVV0USO6I6UCAS127785-64-2ChEBI61739

Structure

InChIKeyYHSKJPXGXIYLHB-OTNPUQRPSA-NSMILES

CC[C@@H](C)[C@@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CC=CC=C2)N(C)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)C(NC1=O)C(C)C)[C@H](C)C(C)C

Targets

O13332AUR1

What you can answer from here — as of February 21, 2021

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

14Drug interactionsStructured to mechanism, not free text

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Basifungin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account